ArticleFrontiers in pediatrics2025
Perioperative care in pediatric OTC deficiency and goldenhar syndrome: a case report.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ornithine transcarbamylase deficiency (OTCD) is an X-linked disorder disrupting the urea cycle in 1 per 56,000 births. Goldenhar syndrome (GS), characterized by craniofacial and vertebral anomalies, is seen in 1 per 3,000-5,000 births. Understanding the pathophysiology and manifestations of both is paramount for developing a perioperative plan. This case report presents a 21-month-old infant with both OTCD and GS undergoing hemifacial malformation correction surgery, the first such report in medical literature. The patient initially presented with lethargy, somnolence, headache, and seizures due to acute liver failure and metabolic acidosis. Diagnosis of OTCD was confirmed through elevated ammonia levels and urine organic acids analysis. The surgical plan involved mandible reconstruction using an autologous costochondral graft. Preoperative management included a low-protein diet and sodium benzoate administration to control ammonia levels. Anesthesia induction and maintenance were carefully managed, with close monitoring of metabolic parameters. The surgery lasted 4 h, during which the patient required transfusion therapy due to easy bleeding. Postoperatively, the patient was monitored in the Pediatric Intensive Care Unit for 48 h before transfer to the general ward. The importance of meticulous preoperative assessment, airway planning, and vigilant intraoperative management in OTCD and GS is underscored. This case highlights the challenges in managing rare comorbidities and emphasizes the need for a multidisciplinary approach. The collaborative effort between specialties led to successful management of this complex case, providing valuable insights for future similar scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.